DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Invega (Paliperidone) - Insomnia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Insomnia (23)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include insomnia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female, weighing 54.4 kg (119.7 pounds)

Reactions: Treatment Noncompliance, Suicidal Ideation, Speech Disorder, Thinking Abnormal, Unevaluable Event, Flashback, Crying, Rhinorrhoea, Rash, Drug Prescribing Error, LIP Ulceration, Abnormal Weight Gain, Discomfort, Activities of Daily Living Impaired, Insomnia, Disturbance in Attention, Inappropriate Affect

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-05-15
    End date: 2012-05-01

Invega
    Dosage: half tablet of 6 mg
    Administration route: Oral
    Start date: 2012-05-01

Lamictal
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-06-01

Lamictal
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-06-01
    End date: 2012-06-01

Invega
    Administration route: Oral
    Start date: 2011-05-01
    End date: 2012-05-01



Possible Invega side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Malaise, Insomnia, Abnormal Behaviour, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-12-26
    End date: 2012-01-18

Invega
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-02-06

Other drugs received by patient: Zoloft; Nitrazepam; Alprazolam; Silece; Diazepam; Doral



Possible Invega side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male, weighing 42.0 kg (92.4 pounds)

Reactions: Pneumonia, Ileus, Insomnia

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2011-04-16
    End date: 2011-04-20

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-08
    End date: 2011-04-15

Zyprexa
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type

Invega
    Administration route: Oral
    Start date: 2011-04-16
    End date: 2011-04-20

Invega
    Administration route: Oral
    Start date: 2011-04-26

Risperdal
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-04-25

Invega
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    Start date: 2011-04-21
    End date: 2011-04-25

Other drugs received by patient: Clonazepam; Flunitrazepam; Magmitt; Phenobarbital TAB; Depakene; Diazepam; Nelurolen; Clonazepam; Magmitt; Clonazepam; Clonazepam



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-29

Patient: female, weighing 54.4 kg (119.7 pounds)

Reactions: Insomnia, Drug Prescribing Error, Suicidal Ideation, Abnormal Weight Gain, Discomfort

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-05-15
    End date: 2012-05-01

Invega
    Dosage: half tablet of 6 mg
    Administration route: Oral

Invega
    Administration route: Oral
    Start date: 2011-05-01
    End date: 2012-05-01



Possible Invega side effects in female

Reported by a physician from Belgium on 2012-06-29

Patient: female, weighing 97.0 kg (213.4 pounds)

Reactions: Psychotic Disorder, Overdose, Insomnia, Mental Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia

Paliperidone
    Indication: Product Used FOR Unknown Indication

Zyprexa
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Product Used FOR Unknown Indication



Possible Invega side effects in female

Reported by a physician from Belgium on 2012-05-29

Patient: female, weighing 97.0 kg (213.4 pounds)

Reactions: Overdose, Psychotic Disorder, Insomnia, Mental Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paliperidone
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Schizophrenia

Zyprexa
    Administration route: Oral
    Indication: Schizophrenia



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: female, weighing 73.5 kg (161.7 pounds)

Reactions: Agitation, Hallucination, Auditory, Insomnia, Mental Disorder, Adverse Event, Abnormal Weight Gain, Lactation Disorder

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Hallucination, Auditory
    Start date: 2011-12-08

Invega
    Administration route: Oral
    Indication: Hallucination, Auditory
    Start date: 2011-12-08



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-06

Patient: female, weighing 73.5 kg (161.7 pounds)

Reactions: Hallucination, Auditory, Insomnia, Abnormal Weight Gain

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Hallucination, Auditory
    Start date: 2011-12-01

Invega
    Administration route: Oral
    Indication: Hallucination, Auditory
    Start date: 2011-12-01



Possible Invega side effects in male

Reported by a physician from Japan on 2012-04-02

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Insomnia, Inappropriate Affect

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-07-04

Invega
    Administration route: Oral
    Start date: 2011-06-08
    End date: 2011-06-10

Invega
    Administration route: Oral
    Start date: 2011-06-11
    End date: 2011-07-03

Other drugs received by patient: Quazepam; Depakene; Sennoside; Depakene



Possible Invega side effects in female

Reported by a physician from Japan on 2012-03-29

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Insomnia, Dysuria, Parkinsonism

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-23

Risperdal
    Administration route: Oral
    End date: 2011-09-25

Risperdal
    Administration route: Oral
    Start date: 2011-10-24
    End date: 2011-11-27

Invega
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    Start date: 2011-10-17

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    Start date: 2011-09-26
    End date: 2011-09-29

Risperdal
    Administration route: Oral
    Start date: 2011-09-30
    End date: 2011-10-02

Invega
    Administration route: Oral
    Start date: 2011-09-25
    End date: 2011-10-16

Risperdal
    Administration route: Oral
    Start date: 2011-11-28
    End date: 2011-12-05

Other drugs received by patient: Nelurolen; Gasmotin; Konsuben; Magmitt; Flunitrazepam; Sorentmin; Pursennid; Rebamipide; Depakene; Trihexyphenidyl HCL



Possible Invega side effects in 28 year old male

Reported by a consumer/non-health professional from Japan on 2012-03-21

Patient: 28 year old male

Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Myalgia, Weight Increased, Fatigue, Anger, Drug Effect Decreased, Dystonia, Blepharospasm, Hypoaesthesia, Convulsion, Aggression, Irritability, Panic Attack, Insomnia, Ocular Hyperaemia, Nervous System Disorder, Tardive Dyskinesia, Withdrawal Syndrome, Extrapyramidal Disorder

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral

Chlorpromazine HCL
    Indication: Product Used FOR Unknown Indication

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    End date: 2011-02-15

Risperdal
    Administration route: Oral

Invega
    Administration route: Oral

Risperdal
    Administration route: Oral

Invega
    Administration route: Oral
    Start date: 2011-02-19

Risperdal
    Administration route: Oral
    Start date: 2011-02-21

Chlorpromazine HCL

Invega
    Administration route: Oral
    Indication: Schizophrenia

Invega
    Administration route: Oral

Invega
    Administration route: Oral
    Start date: 2011-02-16

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral

Other drugs received by patient: Clonazepam; Artane; Dogmatyl; Tegretol



Possible Invega side effects in male

Reported by a physician from Japan on 2012-03-16

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Insomnia, Inappropriate Affect

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-07-04

Invega
    Administration route: Oral
    Start date: 2011-06-08
    End date: 2011-06-10

Invega
    Administration route: Oral
    Start date: 2011-06-11
    End date: 2011-07-03

Other drugs received by patient: Quazepam; Depakene; Sennoside; Depakene



Possible Invega side effects in male

Reported by a physician from Australia on 2012-03-13

Patient: male

Reactions: Mania, Insomnia

Drug(s) suspected as cause:
Invega



Possible Invega side effects in female

Reported by a physician from Japan on 2012-03-08

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Insomnia, Dysuria, Parkinsonism

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2011-09-26
    End date: 2011-09-29

Invega
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    Start date: 2011-10-17

Invega
    Administration route: Oral
    Start date: 2011-09-25
    End date: 2011-10-16

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    End date: 2011-09-25

Risperdal
    Administration route: Oral
    Start date: 2011-11-28
    End date: 2011-12-05

Risperdal
    Administration route: Oral
    Start date: 2011-10-24
    End date: 2011-11-27

Risperdal
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-23

Risperdal
    Administration route: Oral
    Start date: 2011-09-30
    End date: 2011-10-02

Other drugs received by patient: Rebamipide; Sorentmin; Flunitrazepam; Konsuben; Magmitt; Gasmotin; Depakene; Trihexyphenidyl HCL; Nelurolen; Pursennid



Possible Invega side effects in male

Reported by a physician from Australia on 2012-03-02

Patient: male

Reactions: Mania, Insomnia

Drug(s) suspected as cause:
Invega



Possible Invega side effects in female

Reported by a physician from Japan on 2012-02-27

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Dysuria, Insomnia, Parkinsonism

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2011-10-24
    End date: 2011-11-27

Risperdal
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-23

Invega
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    Start date: 2011-10-17

Invega
    Administration route: Oral
    Start date: 2011-09-25
    End date: 2011-10-16

Risperdal
    Administration route: Oral
    Start date: 2011-11-28
    End date: 2011-12-05

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Disorganised Type
    End date: 2011-09-25

Risperdal
    Administration route: Oral
    Start date: 2011-09-26
    End date: 2011-09-29

Risperdal
    Administration route: Oral
    Start date: 2011-09-30
    End date: 2011-10-02

Other drugs received by patient: Gasmotin; Sorentmin; Magmitt; Depakene; Trihexyphenidyl HCL; Nelurolen; Rebamipide; Flunitrazepam; Pursennid; Konsuben



Possible Invega side effects in 41 year old female

Reported by a consumer/non-health professional from United States on 2012-02-10

Patient: 41 year old female, weighing 108.0 kg (237.5 pounds)

Reactions: Gingival Pain, Insomnia, Ear Pain

Drug(s) suspected as cause:
Invega



Possible Invega side effects in 51 year old male

Reported by a physician from Japan on 2012-02-09

Patient: 51 year old male

Reactions: Rhabdomyolysis, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-06-29

Invega
    Administration route: Oral
    Start date: 2011-06-23
    End date: 2011-06-28

Other drugs received by patient: Lendormin; Nitrazepam; Dogmatyl



Possible Invega side effects in 26 year old female

Reported by a consumer/non-health professional from United States on 2012-01-03

Patient: 26 year old female

Reactions: Fatigue, Drug Ineffective, Increased Appetite, Heart Rate Increased, Insomnia, Anger, Abnormal Loss of Weight, Stress

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2011-12-22

Invega
    Administration route: Oral
    Indication: Bipolar I Disorder

Other drugs received by patient: TPN; Bilatin; Flax Seed OIL; Eveninig Primrose OIL; Vitamin D; Horse Chestnut Extract; 5 HTP; Hops



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2011-11-16

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Product Quality Issue, Dermatitis, Feeling Hot, Insomnia, Abnormal Behaviour, Skin Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega



Possible Invega side effects in 28 year old male

Reported by a consumer/non-health professional from Japan on 2011-11-14

Patient: 28 year old male

Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Weight Increased, Myalgia, Fatigue, Anger, Blepharospasm, Dystonia, Hypoaesthesia, Aggression, Convulsion, Panic Attack, Ocular Hyperaemia, Insomnia, Nervous System Disorder, Withdrawal Syndrome, Extrapyramidal Disorder, Tardive Dyskinesia

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-02-19

Invega
    Administration route: Oral

Risperdal
    Administration route: Oral
    Start date: 2011-02-21

Risperdal
    Administration route: Oral

Invega
    Administration route: Oral

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    End date: 2011-02-15

Invega
    Administration route: Oral
    Start date: 2011-02-16

Chlorpromazine HCL
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Tegretol; Clonazepam; Artane; Dogmatyl



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-27

Patient: female, weighing 113.4 kg (249.5 pounds)

Reactions: Vomiting, Hallucination, Visual, Nausea, Hallucination, Auditory, Insomnia, Depression, Impaired Gastric Emptying

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-19

Invega
    Administration route: Oral
    Start date: 2011-09-30
    End date: 2011-10-11

Invega
    Administration route: Oral
    Start date: 2011-09-23
    End date: 2011-09-29

Invega
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-06-01
    End date: 2011-09-22

Other drugs received by patient: Ativan; Effexor XR; Lamictal; Dilaudid



Possible Invega side effects in 51 year old male

Reported by a physician from Japan on 2011-10-17

Patient: 51 year old male

Reactions: Rhabdomyolysis, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-06-29

Invega
    Administration route: Oral
    Start date: 2011-06-23
    End date: 2011-06-28

Other drugs received by patient: Lendormin; Dogmatyl

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017